IGF-1 LR3 Research Guide — What Studies Show (2026)

Overview

IGF-1 LR3 is a modified, longer-acting version of insulin-like growth factor-1, studied for cell growth and muscle hypertrophy research.

What is IGF-1 LR3?

IGF-1 LR3 is a modified version of insulin-like growth factor-1 with two important changes: arginine replaces glutamic acid at position 3 (the 'R3') and a 13-amino-acid extension is added to the N-terminus (the 'L' for long). These modifications dramatically reduce binding to IGF binding proteins, leaving more free IGF-1 LR3 available to bind receptors, and extend the half-life from minutes to roughly a day.

The research interest is muscle hypertrophy. IGF-1 is one of the primary downstream mediators of growth hormone's anabolic effects, and IGF-1 LR3 allows researchers to bypass the GH axis and directly stimulate IGF-1 receptors. Some research has examined IGF-1 LR3's effects on satellite cell activation and potential hyperplasia (increase in muscle fiber number, not just size).

The side effect profile is more concerning than most peptides on this list. Hypoglycemia is the major acute risk — IGF-1 LR3 has insulin-like activity and can cause significant blood sugar drops. Long-term concerns include the theoretical (and contested) link between elevated IGF-1 signaling and cancer risk, fluid retention, and acromegaly-like effects with extended use.

Vendor quality is a significant problem. IGF-1 LR3 is technically challenging to manufacture, and many products sold under this name fail HPLC and mass spectrometry purity testing. Researchers should request comprehensive third-party testing and consider that some vendor material may be a mix of fragments and impurities rather than full-length IGF-1 LR3.

Top Research Uses

• Muscle research
• Recovery
• Cell growth research
• Body composition
• Hyperplasia research

Mechanism of Action

Binds IGF-1 receptors with extended half-life due to reduced binding to IGFBPs and an N-terminal extension

Research Parameters

Dosing ranges cited from published research literature. These are not recommendations for human use. IGF-1 LR3 is a research compound — not for human consumption.

Research Strength: Moderate

IGF-1 LR3 has a moderate research base, with a reasonable number of studies examining its proposed mechanisms. More research is ongoing.

Vendor & Sourcing Notes

Quality varies significantly; many products sold as IGF-1 LR3 fail purity testing

Always request third-party HPLC purity reports and mass spectrometry verification when sourcing research peptides. Quality varies significantly between suppliers.